R01DK127821
Project Grant
Overview
Grant Description
The Gut Endoderm: Origin, Formation and Fate - Project Summary / Abstract
The gut endoderm is the precursor tissue of the respiratory and digestive tracts, as well as their associated visceral organs. In this project, we will utilize a suite of state-of-the-art technologies to address fundamental questions regarding the mechanisms of mammalian gut endoderm cell lineage commitment and tissue morphogenesis. Additionally, we aim to probe the developmental origin and fate of cells that comprise the gut endoderm, using the mouse model.
Our previous studies have provided a paradigm shift in our understanding of the origin and mechanism of formation of the gut endoderm. Through fate mapping, live imaging, and more recently single-cell transcriptomic methods, we have demonstrated that the gut endoderm of mice consists of cells from two distinct developmental origins: embryonic definitive endoderm and extra-embryonic visceral endoderm. This dual origin challenges the prevailing view of germ layer formation in mammals, which posits that endoderm, along with mesoderm and ectoderm, derives solely from pluripotent epiblast. Furthermore, we have shown that the gut endoderm forms through a novel intercalation mechanism and identified SOX17 as a critical regulator of this process.
The broad aim of this project is to use molecular, genomic, embryological, and imaging techniques to investigate fundamental open questions pertaining to the origin, formation, and fate of the gut endoderm in mammals. Specific Aim 1 will investigate the dynamic cellular behaviors driving gut endoderm morphogenesis. Specific Aim 2 will probe the mechanism(s) by which the SOX17 transcription factor drives gut endoderm cell fate specification, tissue morphogenesis, and communication between embryonic definitive endoderm and extra-embryonic visceral endoderm cells as they form a congruent epithelium. Specific Aim 3 will determine whether descendants of extra-embryonic visceral endoderm cells persist throughout embryonic development and whether they will ultimately contribute to the endodermal organs of the adult.
A rigorous understanding of the normal gut endoderm, encompassing its origin, formation, and fate, will underpin logical efforts to direct the differentiation of cells into endoderm identities. This knowledge will also aid in generating bona fide endodermal organoids for development and disease modeling and screening. Additionally, it will help us understand disease progression and design new therapeutic strategies for these vital organ systems when they fail.
The gut endoderm is the precursor tissue of the respiratory and digestive tracts, as well as their associated visceral organs. In this project, we will utilize a suite of state-of-the-art technologies to address fundamental questions regarding the mechanisms of mammalian gut endoderm cell lineage commitment and tissue morphogenesis. Additionally, we aim to probe the developmental origin and fate of cells that comprise the gut endoderm, using the mouse model.
Our previous studies have provided a paradigm shift in our understanding of the origin and mechanism of formation of the gut endoderm. Through fate mapping, live imaging, and more recently single-cell transcriptomic methods, we have demonstrated that the gut endoderm of mice consists of cells from two distinct developmental origins: embryonic definitive endoderm and extra-embryonic visceral endoderm. This dual origin challenges the prevailing view of germ layer formation in mammals, which posits that endoderm, along with mesoderm and ectoderm, derives solely from pluripotent epiblast. Furthermore, we have shown that the gut endoderm forms through a novel intercalation mechanism and identified SOX17 as a critical regulator of this process.
The broad aim of this project is to use molecular, genomic, embryological, and imaging techniques to investigate fundamental open questions pertaining to the origin, formation, and fate of the gut endoderm in mammals. Specific Aim 1 will investigate the dynamic cellular behaviors driving gut endoderm morphogenesis. Specific Aim 2 will probe the mechanism(s) by which the SOX17 transcription factor drives gut endoderm cell fate specification, tissue morphogenesis, and communication between embryonic definitive endoderm and extra-embryonic visceral endoderm cells as they form a congruent epithelium. Specific Aim 3 will determine whether descendants of extra-embryonic visceral endoderm cells persist throughout embryonic development and whether they will ultimately contribute to the endodermal organs of the adult.
A rigorous understanding of the normal gut endoderm, encompassing its origin, formation, and fate, will underpin logical efforts to direct the differentiation of cells into endoderm identities. This knowledge will also aid in generating bona fide endodermal organoids for development and disease modeling and screening. Additionally, it will help us understand disease progression and design new therapeutic strategies for these vital organ systems when they fail.
Funding Goals
<P>THE GOALS ARE:</P><UL><LI>TO FOSTER FUNDAMENTAL CREATIVE DISCOVERIES, INNOVATIVE RESEARCH STRATEGIES, AND THEIR APPLICATIONS AS A BASIS FOR ULTIMATELY PROTECTING AND IMPROVING HEALTH;</LI><LI>TO DEVELOP, MAINTAIN, AND RENEW SCIENTIFIC HUMAN AND PHYSICAL RESOURCES THAT WILL ENSURE THE NATION'S CAPABILITY TO PREVENT DISEASE;</LI><LI>TO EXPAND THE KNOWLEDGE BASE IN MEDICAL AND ASSOCIATED SCIENCES IN ORDER TO ENHANCE THE NATION'S ECONOMIC WELL-BEING AND ENSURE A CONTINUED HIGH RETURN ON THE PUBLIC INVESTMENT IN RESEARCH; AND</LI><LI>TO EXEMPLIFY AND PROMOTE THE HIGHEST LEVEL OF SCIENTIFIC INTEGRITY, PUBLIC ACCOUNTABILITY, AND SOCIAL RESPONSIBILITY IN THE CONDUCT OF SCIENCE.</LI></UL><P>IN REALIZING THESE GOALS, THE NIH PROVIDES LEADERSHIP AND DIRECTION TO PROGRAMS DESIGNED TO IMPROVE THE HEALTH OF THE NATION BY CONDUCTING AND SUPPORTING RESEARCH:</P><UL><LI>IN THE CAUSES, DIAGNOSIS, PREVENTION, AND CURE OF HUMAN DISEASES;</LI><LI>IN THE PROCESSES OF HUMAN GROWTH AND DEVELOPMENT;</LI><LI>IN THE BIOLOGICAL EFFECTS OF ENVIRONMENTAL CONTAMINANTS;</LI><LI>IN THE UNDERSTANDING OF MENTAL, ADDICTIVE AND PHYSICAL DISORDERS; AND</LI><LI>IN DIRECTING PROGRAMS FOR THE COLLECTION, DISSEMINATION, AND EXCHANGE OF INFORMATION IN MEDICINE AND HEALTH, INCLUDING THE DEVELOPMENT AND SUPPORT OF MEDICAL LIBRARIES AND THE TRAINING OF MEDICAL LIBRARIANS AND OTHER HEALTH INFORMATION SPECIALISTS.</LI></UL>
Grant Program (CFDA)
Awarding / Funding Agency
Place of Performance
New York,
New York
100656007
United States
Geographic Scope
Single Zip Code
Related Opportunity
Analysis Notes
Amendment Since initial award the End Date has been extended from 01/31/25 to 04/30/30 and the total obligations have increased 427% from $648,756 to $3,418,174.
Sloan-Kettering Institute For Cancer Research was awarded
Gut Endoderm Origin & Fate: Investigating Mammalian Development
Project Grant R01DK127821
worth $3,418,174
from the National Institute of Diabetes and Digestive and Kidney Diseases in February 2021 with work to be completed primarily in New York New York United States.
The grant
has a duration of 9 years 2 months and
was awarded through assistance program 93.847 Diabetes, Digestive, and Kidney Diseases Extramural Research.
The Project Grant was awarded through grant opportunity NIH Research Project Grant (Parent R01 Clinical Trial Not Allowed).
Status
(Ongoing)
Last Modified 6/22/26
Period of Performance
2/1/21
Start Date
4/30/30
End Date
Funding Split
$3.4M
Federal Obligation
$0.0
Non-Federal Obligation
$3.4M
Total Obligated
Activity Timeline
Transaction History
Modifications to R01DK127821
Additional Detail
Award ID FAIN
R01DK127821
SAI Number
R01DK127821-2960606695
Award ID URI
SAI UNAVAILABLE
Awardee Classifications
Nonprofit With 501(c)(3) IRS Status (Other Than An Institution Of Higher Education)
Awarding Office
75NK00 NIH National Institute of Diabetes and Digestive and Kidney Diseases
Funding Office
75NK00 NIH National Institute of Diabetes and Digestive and Kidney Diseases
Awardee UEI
KUKXRCZ6NZC2
Awardee CAGE
6X133
Performance District
NY-12
Senators
Kirsten Gillibrand
Charles Schumer
Charles Schumer
Budget Funding
| Federal Account | Budget Subfunction | Object Class | Total | Percentage |
|---|---|---|---|---|
| National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Health and Human Services (075-0884) | Health research and training | Grants, subsidies, and contributions (41.0) | $1,304,636 | 100% |
Modified: 6/22/26